speb/financial-data huggingface dataset:
Financial ratios for 9699.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 885777302.4996657
Buffett classification: The Gruesome
Stock price: 27.118700708461436
Shares outstanding: 27763200
Book value: 916922871.2738938
P/B ratio: 0.8211180406735186
Market cap (USD): 752901911.5091566
Debt to equity: 0.7341205627232306
Current ratio: 1.3803383352059728
Quick ratio: 1.28384664657517
Buyback yield (%): 0
Retained earnings: 786966983.02366
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9699.T — annual report dated 2025-09-30
Total revenue: 1446520861.372813
Gross profit: 586130551.8169583
Operating income: 131965006.72947511
Net income: 81911170.92866756
Capital expenditures: 26117092.866756395
Operating cash flow: 214057873.4858681
Depreciation & amortization: 229131897.71197847
Net tangible assets: 917624495.2893674
Owner earnings: 284925975.77388966
Return on net tangible assets (%): 31.050389046560916
Capex to operating income (%): 19.79092299847017
Buffett classification: The Great
Stock price: 28.869448183041722
P/E ratio: 9.785091028590207
Shares outstanding: 27763200
Book value: 944044414.5356662
P/B ratio: 0.8490154186121109
Market cap (USD): 801508263.795424
Debt to equity: 0.6861959582278933
Current ratio: 1.4027380069591011
Quick ratio: 1.3296674462380926
Effective tax rate (%): 32.58196721311475
Interest coverage ratio: 10.71584699453552
COGS to revenue (%): 59.47997934432178
SG&A to revenue (%): 1.5822063427819104
Free cash flow (dilution-adjusted): 183304172.2745626
Buyback yield (%): 0
Retained earnings: 824751009.4212651
Inventory turnover: 19.9615925058548
Receivables turnover: 4.8586831219909135
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.355648216177018
FCF margin (%): 12.672072499569673
Revenue growth (%): 3.78866232157102
Rule of 40 score: 16.460734821140694
Financial ratios for 9699.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 917624495.2893674
Buffett classification: The Gruesome
Stock price: 28.869448183041722
Shares outstanding: 27763200
Book value: 944044414.5356662
P/B ratio: 0.8490154186121109
Market cap (USD): 801508263.795424
Debt to equity: 0.6861959582278933
Current ratio: 1.4027380069591011
Quick ratio: 1.3296674462380926
Buyback yield (%): 0
Retained earnings: 824751009.4212651
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9699.T — quarterly report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.350618550092946
Shares outstanding: 27763200
Market cap (USD): 842630292.9299405
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9866.HK — annual report dated 2022-12-31
Total revenue: 7078816235.632184
Gross profit: 739079454.0229886
Operating income: -2247221120.6896553
Net income: -2074296551.724138
Capital expenditures: 1001326436.7816092
Operating cash flow: -555460919.5402299
Depreciation & amortization: 573858477.0114943
Net tangible assets: 3398787643.678161
Owner earnings: -2501764511.4942527
Return on net tangible assets (%): -73.60755580442348
Buffett classification: The Gruesome
Stock price: 10.077021822849808
Shares outstanding: 2357167022
Book value: 3461140660.9195404
P/B ratio: 6.862831028220981
Market cap (USD): 23753223520.795895
Debt to equity: 1.505444209621446
Current ratio: 1.290013136597981
Quick ratio: 1.1113649565186328
Interest coverage ratio: -46.938499351771824
COGS to revenue (%): 89.55927898929299
R&D to revenue (%): 21.994271356940992
SG&A to revenue (%): 19.726520934922377
Free cash flow (dilution-adjusted): -1887177873.5632184
Buyback yield (%): 0
Retained earnings: -10045147988.505747
Inventory turnover: 5.3867035444306985
Receivables turnover: 6.272713117419402
Capitalized R&D asset: 1556934051.724138
ROCI (R&D-adjusted, %): -13.741619091338167
FCF margin (%): -26.659512137973746
Rule of 40 score: -26.659512137973746
Financial ratios for 9866.HK — annual report dated 2023-12-31
Total revenue: 7822494092.8270035
Gross profit: 429225879.04360056
Operating income: -3186383122.3628693
Net income: -2914170604.781997
Capital expenditures: 2006709845.2883263
Operating cash flow: -194310267.22925457
Depreciation & amortization: 690216736.9901546
Net tangible assets: 3559674542.8973274
Owner earnings: -4230663713.0801687
Return on net tangible assets (%): -118.84973365111921
Buffett classification: The Gruesome
Stock price: 9.423815620998719
Shares outstanding: 2357167022
Book value: 4162590154.711672
P/B ratio: 5.3364627738051436
Market cap (USD): 22213507403.22663
Debt to equity: 1.1733017038509512
Current ratio: 1.2176907807860036
Quick ratio: 1.1263776660125047
Interest coverage ratio: -56.142502416177244
COGS to revenue (%): 94.5129280514614
R&D to revenue (%): 24.149403394764782
SG&A to revenue (%): 21.48182313787174
Free cash flow (dilution-adjusted): -2544494796.061885
Buyback yield (%): 0
Retained earnings: -12764843037.974684
Inventory turnover: 9.959997354921418
Receivables turnover: 6.180297031980392
Capitalized R&D asset: 2932231468.6636114
ROCI (R&D-adjusted, %): -21.621470381835035
Rosenberg metric: -0.19901522138093022
FCF margin (%): -32.527922244071895
Revenue growth (%): 10.50568106926432
Rule of 40 score: -22.022241174807576
Financial ratios for 9866.HK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.252252252252253
Shares outstanding: 2357167022
Market cap (USD): 17094769844.234236
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9866.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.503865979381444
Shares outstanding: 2357167022
Market cap (USD): 10616364358.10567
Buyback yield (%): 0
Retained earnings: -15488795890.41096
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9866.HK — annual report dated 2024-12-31
Total revenue: 9004323150.68493
Gross profit: 889419452.0547945
Operating income: -2996448356.1643834
Net income: -3068727260.2739725
Capital expenditures: 1220653972.6027398
Operating cash flow: -1075228493.150685
Depreciation & amortization: 1054887808.2191781
Net tangible assets: 785668493.150685
Owner earnings: -3234493424.657534
Return on net tangible assets (%): -411.6867932028915
Buffett classification: The Gruesome
Stock price: 4.503865979381444
Shares outstanding: 2357167022
Book value: 1850211369.8630142
P/B ratio: 5.737919748537533
Market cap (USD): 10616364358.10567
Debt to equity: 2.5042161417618103
Current ratio: 0.9931796819773014
Quick ratio: 0.8794402094884526
Interest coverage ratio: -27.39865574932706
COGS to revenue (%): 90.12230639471066
R&D to revenue (%): 19.834162156415612
SG&A to revenue (%): 21.986802412521513
Free cash flow (dilution-adjusted): -2591777123.287671
Buyback yield (%): 0
Retained earnings: -15488795890.41096
Inventory turnover: 8.358534365293712
Receivables turnover: 5.532912938443278
Capitalized R&D asset: 3565407680.0491405
ROCI (R&D-adjusted, %): -30.240507345516036
Rosenberg metric: 0.2436065151597082
FCF margin (%): -28.78369734087701
Revenue growth (%): 15.108085015259132
Rule of 40 score: -13.675612325617877
Financial ratios for 9866.HK — quarterly report dated 2025-03-31
Total revenue: 1657676170.7988982
Gross profit: 126660330.5785124
Operating income: -884039669.4214876
Net income: -929756611.570248
Capital expenditures: 0
Net tangible assets: -82123002.75482094
Owner earnings: -929756611.570248
Buffett classification: The Gruesome
Stock price: 3.7210796915167093
Shares outstanding: 2357167022
Book value: -37442837.46556473
Market cap (USD): 8771206335.07712
Debt to equity: -111.66345393345232
Current ratio: 0.8369266437412074
Quick ratio: 0.6907538631536932
Interest coverage ratio: -26.211204678553635
COGS to revenue (%): 92.3591632183824
R&D to revenue (%): 26.435186035348202
SG&A to revenue (%): 36.567196486102844
Buyback yield (%): 0
Inventory turnover: 1.2781790048000818
Receivables turnover: 1.1377939706055866
Capitalized R&D asset: 438209779.6143251
ROCI (R&D-adjusted, %): -10.26730463025996
Rule of 40 score: 0
Financial ratios for 9866.HK — quarterly report dated 2025-06-30
Total revenue: 2651138772.6638775
Gross profit: 264647559.27475592
Operating income: -684638493.7238494
Net income: -696624965.1324965
Capital expenditures: 0
Net tangible assets: -200097071.12970713
Owner earnings: -696624965.1324965
Buffett classification: The Gruesome
Stock price: 3.4904458598726116
Shares outstanding: 2357167022
Book value: 922728591.3528595
P/B ratio: 8.916558942760515
Market cap (USD): 8227563872.968153
Debt to equity: 4.680258235987981
Current ratio: 0.8430737482652777
Quick ratio: 0.7107178241941715
Interest coverage ratio: -23.07358001015286
COGS to revenue (%): 90.01758934675318
R&D to revenue (%): 15.819269790908514
SG&A to revenue (%): 18.296618936679664
Buyback yield (%): 0
Retained earnings: -17406933612.27336
Inventory turnover: 2.0757542728145166
Receivables turnover: 1.2102065714948387
Capitalized R&D asset: 712991347.3206773
ROCI (R&D-adjusted, %): -9.216004198061707
Rosenberg metric: 0.3148885194157194
Revenue growth (%): 59.931041983078714
Rule of 40 score: 59.931041983078714
Financial ratios for 9866.HK — quarterly report dated 2025-09-30
Total revenue: 3060937500
Gross profit: 424799016.85393256
Operating income: -494595786.5168539
Net income: -488832162.92134833
Capital expenditures: 0
Net tangible assets: 483437359.5505618
Owner earnings: -488832162.92134833
Return on net tangible assets (%): -101.1159260376157
Buffett classification: The Gruesome
Stock price: 7.3778920308483285
Shares outstanding: 2357167022
Book value: 1697783707.8651695
P/B ratio: 10.243309384126448
Market cap (USD): 17390923786.992287
Debt to equity: 2.2865628686440176
Current ratio: 0.9367163504487322
Quick ratio: 0.8256389343524014
Interest coverage ratio: -15.826496125981988
COGS to revenue (%): 86.12193104714054
R&D to revenue (%): 10.969155324603816
SG&A to revenue (%): 19.20115169973215
Buyback yield (%): 0
Inventory turnover: 2.5100433530069877
Receivables turnover: 1.4976024754492523
Capitalized R&D asset: 761360048.6727555
ROCI (R&D-adjusted, %): -7.903332451310356
Rosenberg metric: 0.38186688762962834
Revenue growth (%): 15.457460452903968
Rule of 40 score: 15.457460452903968
Financial ratios for 9866.HK — quarterly report dated 2025-12-31
Total revenue: 4950034428.571428
Gross profit: 867722714.2857143
Operating income: 115324285.71428572
Net income: 40388285.71428572
Capital expenditures: 0
Net tangible assets: 561874428.5714285
Owner earnings: 40388285.71428572
Return on net tangible assets (%): 7.1881338001042945
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.262210796915166
P/E ratio: 76.77912997501518
Shares outstanding: 2357167022
Book value: 1813222428.5714264
P/B ratio: 6.840809796883756
Market cap (USD): 12403909753.30077
Debt to equity: 2.4631077095025087
Current ratio: 0.9751913665630887
Quick ratio: 0.866632245120333
Effective tax rate (%): 5.760980796730678
Interest coverage ratio: 3.935406815190367
COGS to revenue (%): 82.47037011950364
R&D to revenue (%): 5.846868424378347
SG&A to revenue (%): 7.779091637486735
Buyback yield (%): 0
Retained earnings: -18289861571.42857
Inventory turnover: 3.3497445859464947
Receivables turnover: 1.6906123365051406
Capitalized R&D asset: 652779484.8150064
ROCI (R&D-adjusted, %): 0.7856832235603118
Rosenberg metric: 1.3191715255702265
Revenue growth (%): 61.7162855684387
Rule of 40 score: 61.7162855684387
Financial ratios for 9866.HK — annual report dated 2025-12-31
Total revenue: 12498215714.285715
Gross profit: 1702243571.4285715
Operating income: -2005891142.857143
Net income: -2134657285.7142856
Capital expenditures: 850250714.2857143
Operating cash flow: 427516000
Depreciation & amortization: 1339325714.2857144
Net tangible assets: 561874428.5714285
Owner earnings: -1645582285.7142854
Return on net tangible assets (%): -292.8736746212486
Buffett classification: The Gruesome
Stock price: 5.262210796915166
Shares outstanding: 2357167022
Book value: 1813222428.5714264
P/B ratio: 6.840809796883756
Market cap (USD): 12403909753.30077
Debt to equity: 2.4631077095025087
Current ratio: 0.9751913665630887
Quick ratio: 0.866632245120333
Interest coverage ratio: -15.86136088418161
COGS to revenue (%): 86.38010728617148
R&D to revenue (%): 12.121722289273063
SG&A to revenue (%): 16.869670882163636
Free cash flow (dilution-adjusted): -694763000
Buyback yield (%): 0
Retained earnings: -18289861571.42857
Inventory turnover: 8.858644749986345
Receivables turnover: 4.26858398174249
Capitalized R&D asset: 3334971742.535114
ROCI (R&D-adjusted, %): -22.477643665873217
Rosenberg metric: 0.4551260039214067
FCF margin (%): -5.558897492910702
Revenue growth (%): 38.80238975358203
Rule of 40 score: 33.243492260671324
Financial ratios for 9991.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.365384615384615
Shares outstanding: 161122226
Market cap (USD): 703360486.576923
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9991.HK — annual report dated 2022-12-31
Total revenue: 1206987212.6436782
Gross profit: 492087931.0344828
Operating income: 6672701.149425288
Net income: -87697413.79310344
Capital expenditures: 29735057.47126437
Operating cash flow: 54971982.75862069
Depreciation & amortization: 28238936.781609196
Net tangible assets: 488164080.45977014
Owner earnings: -89193534.48275861
Return on net tangible assets (%): -18.271220282891974
Capex to operating income (%): 445.6224968778261
Buffett classification: The Gruesome
Stock price: 1.6867779204107831
Shares outstanding: 161122226
Book value: 815565804.5977011
P/B ratio: 0.33323787212767886
Market cap (USD): 271777413.30423623
Debt to equity: 0.42515227246862325
Current ratio: 2.0091890988946517
Quick ratio: 1.7530544091024531
Interest coverage ratio: 0.8159600822249943
COGS to revenue (%): 59.23006259886906
SG&A to revenue (%): 36.257133541516104
Free cash flow (dilution-adjusted): -2732471.264367815
Buyback yield (%): 23.61191031302656
Retained earnings: -32782327.586206898
Inventory turnover: 5.276473838198848
Receivables turnover: 3.040666217840131
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.721056696929353
FCF margin (%): -0.2263877558721481
Rule of 40 score: -0.2263877558721481
Financial ratios for 9991.HK — annual report dated 2023-12-31
Total revenue: 1239382981.715893
Gross profit: 547903938.1153305
Operating income: -24074261.603375528
Net income: -31332770.745428972
Capital expenditures: 23207735.58368495
Operating cash flow: 63045710.26722925
Depreciation & amortization: 35390717.299578056
Net tangible assets: 483805344.5850914
Owner earnings: -19149789.029535867
Return on net tangible assets (%): -3.9581598764599457
Buffett classification: The Gruesome
Stock price: 0.8988476312419974
Shares outstanding: 161122226
Book value: 823028973.2770745
P/B ratio: 0.175965046046784
Market cap (USD): 144824331.18053776
Debt to equity: 0.47070288201655036
Current ratio: 1.940090900382122
Quick ratio: 1.6619836294159596
Interest coverage ratio: -4.140092879256966
COGS to revenue (%): 55.792200942054905
SG&A to revenue (%): 41.81711942549336
Free cash flow (dilution-adjusted): 16118706.047819972
Buyback yield (%): 0
Retained earnings: -71249929.67651196
Inventory turnover: 4.704182119496783
Receivables turnover: 3.310735679548911
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.548464114430756
FCF margin (%): 1.300542793116624
Revenue growth (%): 2.684019245014039
Rule of 40 score: 3.984562038130663
Financial ratios for 9991.HK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.1891891891891893
Shares outstanding: 161122226
Market cap (USD): 191604809.2972973
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9991.HK — annual report dated 2024-12-31
Total revenue: 1290716301.369863
Gross profit: 614634794.520548
Operating income: -14779589.04109589
Net income: -18956712.328767125
Capital expenditures: 18096986.301369864
Operating cash flow: 13873698.630136987
Depreciation & amortization: 33541232.87671233
Net tangible assets: 432449041.0958904
Owner earnings: -3512465.7534246594
Return on net tangible assets (%): -0.812226509861959
Buffett classification: The Gruesome
Stock price: 0.9304123711340206
Shares outstanding: 161122226
Book value: 791860136.9863013
P/B ratio: 0.1893138766974513
Market cap (USD): 149910112.33505154
Debt to equity: 0.436474962110197
Current ratio: 1.9250330281834271
Quick ratio: 1.6268550418312515
Interest coverage ratio: -2.7673583502193035
COGS to revenue (%): 52.380333783014606
SG&A to revenue (%): 43.512856671176216
Free cash flow (dilution-adjusted): -25103013.69863014
Buyback yield (%): 8.7268734241124
Retained earnings: -94765068.49315068
Inventory turnover: 4.41670194077708
Receivables turnover: 3.919663820659979
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6702830769954813
FCF margin (%): -1.9448901103974445
Revenue growth (%): 4.141844805945325
Rule of 40 score: 2.19695469554788
Financial ratios for 9991.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.9304123711340206
Shares outstanding: 161122226
Market cap (USD): 149910112.33505154
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9991.HK — quarterly report dated 2025-03-31
Total revenue: 284347107.43801653
Gross profit: 136729614.32506886
Operating income: -11568870.523415979
Net income: -8688705.23415978
Capital expenditures: 0
Net tangible assets: 426297796.1432507
Owner earnings: -8688705.23415978
Return on net tangible assets (%): -2.038177375714154
Buffett classification: The Gruesome
Stock price: 0.9383033419023136
Shares outstanding: 161122226
Book value: 785114600.5509641
P/B ratio: 0.19255981611403775
Market cap (USD): 151181523.11053982
Debt to equity: 0.4241254106189337
Current ratio: 1.9857632455207805
Quick ratio: 1.6501761111055364
Interest coverage ratio: -6.70418263090677
COGS to revenue (%): 51.914540099595044
SG&A to revenue (%): 47.028425274661394
Buyback yield (%): 0
Retained earnings: -103975895.31680441
Inventory turnover: 0.9425401284215027
Receivables turnover: 1.0224665676077265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3266556699089886
Rule of 40 score: 0
Financial ratios for 9991.HK — quarterly report dated 2025-06-30
Total revenue: 356019665.2719665
Gross profit: 172273919.10739192
Operating income: -1307949.790794979
Net income: -2852719.6652719667
Capital expenditures: 0
Net tangible assets: 425683263.5983264
Owner earnings: -2852719.6652719667
Return on net tangible assets (%): -0.6701507691793552
Buffett classification: The Gruesome
Stock price: 0.8866242038216561
Shares outstanding: 161122226
Book value: 790320502.0920503
P/B ratio: 0.1807556111312728
Market cap (USD): 142854865.34522292
Debt to equity: 0.4183139513337632
Current ratio: 1.9696339978404707
Quick ratio: 1.6854344150006422
Interest coverage ratio: -0.7960275019098548
COGS to revenue (%): 51.61112266767894
SG&A to revenue (%): 45.52986080016109
Buyback yield (%): 0
Retained earnings: -110017154.81171548
Inventory turnover: 1.378149317806898
Receivables turnover: 1.0765706607554961
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.149864134690431
Revenue growth (%): 25.20600912023469
Rule of 40 score: 25.20600912023469
Financial ratios for 9991.HK — quarterly report dated 2025-09-30
Total revenue: 302841853.9325843
Gross profit: 158619101.1235955
Operating income: -3597893.258426966
Net income: -13302528.08988764
Capital expenditures: 0
Net tangible assets: 427512921.3483146
Owner earnings: -13302528.08988764
Return on net tangible assets (%): -3.1116084276314666
Buffett classification: The Gruesome
Stock price: 1.3753213367609254
Shares outstanding: 161122226
Book value: 775511797.752809
P/B ratio: 0.28574012140927907
Market cap (USD): 221594835.24421594
Debt to equity: 0.4352241832323851
Current ratio: 1.8735586631761707
Quick ratio: 1.5643726593055034
Interest coverage ratio: -2.611847471451876
COGS to revenue (%): 47.62312439187954
SG&A to revenue (%): 48.94918640555709
Buyback yield (%): 0
Retained earnings: -125832584.26966292
Inventory turnover: 0.9184930097764739
Receivables turnover: 1.0928668778164496
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4149101376263583
Revenue growth (%): -14.936762355180363
Rule of 40 score: -14.936762355180363
Financial ratios for 9991.HK — quarterly report dated 2025-12-31
Total revenue: 453175428.5714286
Gross profit: 243212428.57142857
Operating income: 27705000
Net income: -1734857.142857143
Capital expenditures: 0
Net tangible assets: 429850857.14285713
Owner earnings: -1734857.142857143
Return on net tangible assets (%): -0.4035951339933186
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.8740359897172236
Shares outstanding: 161122226
Book value: 784513142.8571429
P/B ratio: 0.17950830467220893
Market cap (USD): 140826624.2673522
Debt to equity: 0.4137696318298955
Current ratio: 1.8663473028922704
Quick ratio: 1.6250903937381143
Interest coverage ratio: 18.549497847919653
COGS to revenue (%): 46.331505806013936
SG&A to revenue (%): 44.45916245616645
Buyback yield (%): 0
Retained earnings: -133412142.85714285
Inventory turnover: 1.671259840281276
Receivables turnover: 1.293766183659994
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2076834218994787
Revenue growth (%): 49.640950445479085
Rule of 40 score: 49.640950445479085
Financial ratios for 9991.HK — annual report dated 2025-12-31
Total revenue: 1420783285.7142856
Gross profit: 722816571.4285715
Operating income: 10707142.857142856
Net income: -28511428.57142857
Capital expenditures: 15220571.42857143
Operating cash flow: 60062000
Depreciation & amortization: 31677285.714285713
Net tangible assets: 429850857.14285713
Owner earnings: -12054714.285714287
Return on net tangible assets (%): -2.804394613945834
Capex to operating income (%): 142.15343562374917
Buffett classification: The Gruesome
Stock price: 0.8740359897172236
Shares outstanding: 161122226
Book value: 784513142.8571429
P/B ratio: 0.17950830467220893
Market cap (USD): 140826624.2673522
Debt to equity: 0.4137696318298955
Current ratio: 1.8663473028922704
Quick ratio: 1.6250903937381143
Interest coverage ratio: 1.681548954500583
COGS to revenue (%): 49.125487419766344
SG&A to revenue (%): 46.240730590962755
Free cash flow (dilution-adjusted): 35237000
Buyback yield (%): 1.0364314533312298
Retained earnings: -133412142.85714285
Inventory turnover: 5.555663328485446
Receivables turnover: 4.0561805726339175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2396724287589447
FCF margin (%): 2.4801108201582567
Revenue growth (%): 10.077116420268334
Rule of 40 score: 12.557227240426592
Financial ratios for ABCOTS.NS — annual report dated 2022-03-31
Total revenue: 18444362.389555585
Gross profit: 4586878.544111829
Operating income: 1452841.8831596994
Net income: 901120.9283924568
Capital expenditures: 1998285.6389291838
Operating cash flow: 1789687.4587893973
Depreciation & amortization: 432388.2368455756
Net tangible assets: 5119926.150600026
Owner earnings: -664776.4736911512
Return on net tangible assets (%): -12.984102780725523
Capex to operating income (%): 137.54322903902187
Buffett classification: The Gruesome
Stock price: 0.5795859158644336
P/E ratio: 14.126633187964643
Shares outstanding: 21963620
Book value: 5119926.150600026
P/B ratio: 2.486325864662429
Market cap (USD): 12729804.813398393
Debt to equity: 0.7987080109415728
Current ratio: 1.9304592079853533
Quick ratio: 1.0067564517342562
Effective tax rate (%): 24.778459065840313
Interest coverage ratio: 6.136523143764274
COGS to revenue (%): 75.13127075236159
SG&A to revenue (%): 1.7022298868325996
Free cash flow (dilution-adjusted): -216510.61585124623
Buyback yield (%): 0
Retained earnings: 2108730.0540683107
Inventory turnover: 5.706164405877689
Receivables turnover: 17.39597014925373
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.524194010192982
FCF margin (%): -1.1738579587541007
Rule of 40 score: -1.1738579587541007
Financial ratios for ABCOTS.NS — annual report dated 2023-03-31
Total revenue: 20476552.984165654
Gross profit: 3759866.0170523752
Operating income: 671717.4177831913
Net income: 235444.5797807552
Capital expenditures: 4754896.46772229
Operating cash flow: -2887028.014616322
Depreciation & amortization: 599792.9354445798
Net tangible assets: 5186163.215590743
Owner earnings: -3919658.952496955
Return on net tangible assets (%): -75.57916690152754
Capex to operating income (%): 707.871545658954
Buffett classification: The Gruesome
Stock price: 0.535931790499391
P/E ratio: 49.99478944645629
Shares outstanding: 21963620
Book value: 5186163.215590743
P/B ratio: 2.269693741427578
Market cap (USD): 11771002.192448234
Debt to equity: 2.30382541382485
Current ratio: 1.291151534496987
Quick ratio: 0.44331470034099935
Effective tax rate (%): 24.87076839364142
Interest coverage ratio: 1.6051459673428996
COGS to revenue (%): 81.63818871291545
SG&A to revenue (%): 1.0263365305970704
Free cash flow (dilution-adjusted): -7641924.482338612
Buyback yield (%): 0
Retained earnings: 2176211.936662607
Inventory turnover: 3.1506525407192294
Receivables turnover: 12.488763919739101
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.623989761213969
FCF margin (%): -37.3203658264555
Revenue growth (%): 11.017949830354826
Rule of 40 score: -26.302415996100674
Financial ratios for ABCOTS.NS — annual report dated 2024-03-31
Total revenue: 30223683.894951433
Gross profit: 6790154.69480753
Operating income: 1989039.4531718432
Net income: 803261.781988248
Capital expenditures: 548315.1457009234
Operating cash flow: -3859431.5865211654
Depreciation & amortization: 1180944.9574289483
Net tangible assets: 8210073.150257825
Owner earnings: 1435891.5937162729
Return on net tangible assets (%): 17.489388552782636
Capex to operating income (%): 27.566831056394918
Buffett classification: The Good
Stock price: 2.931861804222649
P/E ratio: 80.16601810815739
Shares outstanding: 21963620
Book value: 8210073.150257826
P/B ratio: 7.843328236172713
Market cap (USD): 64394298.56046066
Debt to equity: 1.7771070259027395
Current ratio: 1.4453074386364855
Quick ratio: 0.6557907478579397
Effective tax rate (%): 20.70741148478284
Interest coverage ratio: 1.8239459851767137
COGS to revenue (%): 77.53366294324645
SG&A to revenue (%): 0.8231386635126112
Free cash flow (dilution-adjusted): -4407746.732222089
Buyback yield (%): 0
Retained earnings: 2990922.172922413
Inventory turnover: 3.014090068468324
Receivables turnover: 6.604352497248572
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.307352847306923
FCF margin (%): -14.583750768245556
Revenue growth (%): 47.601424508915905
Rule of 40 score: 33.01767374067035
Financial ratios for ABCOTS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 8651672.240802675
Buffett classification: The Gruesome
Stock price: 5.129598662207358
Shares outstanding: 21963620
Book value: 8651672.240802675
P/B ratio: 13.022286632390745
Market cap (USD): 112664555.76923077
Debt to equity: 1.3041260882650991
Current ratio: 1.7705616122212227
Quick ratio: 1.2257363205712062
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABCOTS.NS — quarterly report dated 2024-12-31
Total revenue: 6905641.683179857
Gross profit: 1989765.706958853
Operating income: 796852.7800442942
Net income: 474787.2712437347
Capital expenditures: 0
Depreciation & amortization: 237988.11050238955
Owner earnings: 712775.3817461242
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.166103275440028
P/E ratio: 59.74587783560837
Shares outstanding: 21963620
Market cap (USD): 113466329.2225201
Effective tax rate (%): 12.997415468739987
Interest coverage ratio: 2.9376477160414254
COGS to revenue (%): 71.18637487656873
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABCOTS.NS — annual report dated 2025-03-31
Total revenue: 34858089.78255787
Gross profit: 7452945.990180032
Operating income: 2494341.8283843813
Net income: 1193885.9013327097
Capital expenditures: 5779494.973111994
Operating cash flow: -2088812.2515782088
Depreciation & amortization: 1027729.7170914192
Net tangible assets: 12947907.411737198
Owner earnings: -3557879.354687865
Return on net tangible assets (%): -27.478412082732916
Capex to operating income (%): 231.7042077931817
Buffett classification: The Gruesome
Stock price: 5.358268175983195
P/E ratio: 98.5747180229003
Shares outstanding: 21963620
Book value: 12947907.4117372
P/B ratio: 9.089265340954285
Market cap (USD): 117686966.07538801
Debt to equity: 1.496848037675475
Current ratio: 1.6492993959320996
Quick ratio: 0.8695175103226792
Effective tax rate (%): 25.32830276973473
Interest coverage ratio: 2.0525829725829725
COGS to revenue (%): 78.61917839826867
SG&A to revenue (%): 0.8481229716264984
Free cash flow (dilution-adjusted): -7868307.224690203
Buyback yield (%): 0
Retained earnings: 4042015.4313771334
Inventory turnover: 2.8734051694022966
Receivables turnover: 6.23488932288944
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.610750416698636
FCF margin (%): -22.572399330462765
Revenue growth (%): 15.333689644565684
Rule of 40 score: -7.238709685897081
Financial ratios for ABCOTS.NS — quarterly report dated 2025-03-31
Total revenue: 9944599.018003272
Gross profit: 1999602.5251344398
Operating income: 580944.587327566
Net income: 247100.77156885667
Capital expenditures: 0
Depreciation & amortization: 282826.7477203647
Net tangible assets: 12947907.411737198
Owner earnings: 529927.5192892214
Return on net tangible assets (%): 4.092765745365505
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.358268175983195
P/E ratio: 119.06778490429923
Shares outstanding: 21963620
Book value: 12947907.4117372
P/B ratio: 9.089265340954285
Market cap (USD): 117686966.07538801
Debt to equity: 1.496848037675475
Current ratio: 1.6492993959320996
Quick ratio: 0.8695175103226792
Effective tax rate (%): 41.007033605001666
Interest coverage ratio: 1.599575111855023
COGS to revenue (%): 79.89257765431823
Buyback yield (%): 0
Retained earnings: 4042015.4313771334
Inventory turnover: 0.8330258788805144
Receivables turnover: 1.7787398742885339
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.704201377948792
Revenue growth (%): 44.00687835028329
Rule of 40 score: 44.00687835028329
Financial ratios for ABCOTS.NS — quarterly report dated 2025-06-30
Total revenue: 7803721.039082612
Gross profit: 2182869.1785630705
Operating income: 930353.3816990405
Net income: 489059.20898666047
Capital expenditures: 0
Depreciation & amortization: 237935.87643341915
Owner earnings: 726995.0854200796
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.95143926983384
P/E ratio: 89.80699234762086
Shares outstanding: 21963620
Market cap (USD): 108751530.57570793
Effective tax rate (%): 27.508455467869226
Interest coverage ratio: 3.6230576441102755
COGS to revenue (%): 72.02784200472031
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -21.528047285213884
Rule of 40 score: -21.528047285213884
Financial ratios for ABCOTS.NS — quarterly report dated 2025-09-30
Total revenue: 5720225.479143179
Gross profit: 2354554.6786922207
Operating income: 821871.4768883878
Net income: 408184.892897407
Capital expenditures: 0
Depreciation & amortization: 447970.6877113867
Net tangible assets: 16649842.164599774
Owner earnings: 856155.5806087938
Return on net tangible assets (%): 5.142124304512132
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.868094701240135
P/E ratio: 66.0359826047943
Shares outstanding: 21963620
Book value: 16649842.164599773
P/B ratio: 6.421741484696052
Market cap (USD): 106920982.14205186
Debt to equity: 0.9302775315690722
Current ratio: 1.9169992726187588
Quick ratio: 1.0531326351716805
Effective tax rate (%): 22.37468376141675
Interest coverage ratio: 2.7261508544931004
COGS to revenue (%): 58.83807924569952
Buyback yield (%): 0
Inventory turnover: 0.4028339452722825
Receivables turnover: 0.8862354938551936
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.339736403630738
Revenue growth (%): -26.69874473350426
Rule of 40 score: -26.69874473350426
Financial ratios for ABCOTS.NS — quarterly report dated 2025-12-31
Total revenue: 8603620.363150273
Gross profit: 2288270.023393116
Operating income: 601670.9368385875
Net income: 364509.3015484015
Capital expenditures: 0
Depreciation & amortization: 448056.14347777655
Owner earnings: 812565.445026178
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.5889495377074745
P/E ratio: 66.79899589719734
Shares outstanding: 21963620
Market cap (USD): 100789943.84538265
Effective tax rate (%): 28.908490484053186
Interest coverage ratio: 1.9047820567075753
COGS to revenue (%): 73.40340546412429
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 50.40701445284621
Rule of 40 score: 50.40701445284621
Financial ratios for ACRS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.54
Shares outstanding: 139663680
Market cap (USD): 2030709907.1999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACRS — annual report dated 2022-12-31
Total revenue: 29752000
Gross profit: 17792000
Operating income: -85154000
Net income: -86908000
Capital expenditures: 605000
Operating cash flow: -67567000
Depreciation & amortization: 797000
Net tangible assets: 190648000
Owner earnings: -86716000
Return on net tangible assets (%): -45.48487264487432
Buffett classification: The Gruesome
Stock price: 15.75
Shares outstanding: 139663680
Book value: 197621000
P/B ratio: 11.130917058409784
Market cap (USD): 2199702960
Debt to equity: 0.0034611706245793717
Current ratio: 10.554745190992797
Quick ratio: 10.554745190992797
COGS to revenue (%): 40.1989782199516
R&D to revenue (%): 261.53872008604463
SG&A to revenue (%): 84.47499327776285
Free cash flow (dilution-adjusted): -83211000
Buyback yield (%): 0
Retained earnings: -682315000
Receivables turnover: 61.47107438016529
Capitalized R&D asset: 77813000
ROCI (R&D-adjusted, %): -10.71876815118535
FCF margin (%): -279.68203818230705
Rule of 40 score: -279.68203818230705
Financial ratios for ACRS — annual report dated 2023-12-31
Total revenue: 31249000
Gross profit: 13168000
Operating income: -116314000
Net income: -88481000
Capital expenditures: 1309000
Operating cash flow: -78325000
Depreciation & amortization: 863000
Net tangible assets: 157179000
Owner earnings: -88927000
Return on net tangible assets (%): -56.576896404736
Buffett classification: The Gruesome
Stock price: 1.05
Shares outstanding: 139663680
Book value: 157179000
P/B ratio: 0.932992728036188
Market cap (USD): 146646864
Debt to equity: 0.0027102857251922966
Current ratio: 4.163091238046007
Quick ratio: 4.163091238046007
COGS to revenue (%): 57.86105155364971
R&D to revenue (%): 314.83887484399503
SG&A to revenue (%): 99.51678453710518
Free cash flow (dilution-adjusted): -100176000
Buyback yield (%): 0
Retained earnings: -770796000
Receivables turnover: 104.86241610738254
Capitalized R&D asset: 150518710
ROCI (R&D-adjusted, %): -24.185859783301588
Rosenberg metric: -0.05942451775410278
FCF margin (%): -320.57345835066724
Revenue growth (%): 5.031594514654477
Rule of 40 score: -315.54186383601274
Financial ratios for ACRS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.15
Shares outstanding: 139663680
Market cap (USD): 160613232
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACRS — annual report dated 2024-12-31
Total revenue: 18720000
Gross profit: 3262000
Operating income: -52527000
Net income: -132065000
Capital expenditures: 121000
Operating cash flow: -20075000
Depreciation & amortization: 807000
Net tangible assets: 155554000
Owner earnings: -131379000
Return on net tangible assets (%): -84.45877315916016
Buffett classification: The Gruesome
Stock price: 2.48
Shares outstanding: 139663680
Book value: 155554000
P/B ratio: 2.226660364889363
Market cap (USD): 346365926.4
Debt to equity: 0
Current ratio: 3.9862957336371694
Quick ratio: 3.9862957336371694
COGS to revenue (%): 82.57478632478632
R&D to revenue (%): 179.41239316239316
SG&A to revenue (%): 118.60576923076923
Free cash flow (dilution-adjusted): -66862000
Buyback yield (%): 0
Retained earnings: -902861000
Receivables turnover: 58.867924528301884
Capitalized R&D asset: 125181570
ROCI (R&D-adjusted, %): -28.310005765830486
Rosenberg metric: -0.10068710359408034
FCF margin (%): -357.1688034188034
Revenue growth (%): -40.09408301065634
Rule of 40 score: -397.26288642945974
Financial ratios for ACRS — quarterly report dated 2024-12-31
Capital expenditures: 35810000
Buffett classification: The Gruesome
Stock price: 2.48
Shares outstanding: 139663680
Market cap (USD): 346365926.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACRS — quarterly report dated 2025-03-31
Total revenue: 1455000
Gross profit: -61000
Operating income: -17784000
Net income: -15085000
Capital expenditures: 43000
Operating cash flow: -13057000
Depreciation & amortization: 128000
Net tangible assets: 144066000
Owner earnings: -15000000
Return on net tangible assets (%): -10.411894548332015
Buffett classification: The Gruesome
Stock price: 1.53
Shares outstanding: 139663680
Book value: 144066000
P/B ratio: 1.483246778559827
Market cap (USD): 213685430.4
Debt to equity: 0
Current ratio: 5.056707260388584
Quick ratio: 5.056707260388584
COGS to revenue (%): 104.19243986254297
R&D to revenue (%): 796.1512027491409
SG&A to revenue (%): 421.92439862542955
Free cash flow (dilution-adjusted): -17468000
Buyback yield (%): 0
Retained earnings: -917946000
Receivables turnover: 5.82
Capitalized R&D asset: 11584000
ROCI (R&D-adjusted, %): -5.34710855069691
FCF margin (%): -1200.549828178694
Rule of 40 score: -1200.549828178694
Financial ratios for ACRS — quarterly report dated 2025-06-30
Total revenue: 1777000
Gross profit: -73000
Operating income: -16908000
Net income: -15429000
Capital expenditures: 21000
Operating cash flow: -9993000
Depreciation & amortization: 114000
Net tangible assets: 131739000
Owner earnings: -15336000
Return on net tangible assets (%): -11.641199644752124
Buffett classification: The Gruesome
Stock price: 1.42
Shares outstanding: 139663680
Book value: 131739000
P/B ratio: 1.5054192425933093
Market cap (USD): 198322425.6
Debt to equity: 0
Current ratio: 3.8824844442788478
Quick ratio: 3.8824844442788478
COGS to revenue (%): 104.10804727068093
R&D to revenue (%): 644.2881260551492
SG&A to revenue (%): 303.0951041080473
Free cash flow (dilution-adjusted): -13077000
Buyback yield (%): 0
Retained earnings: -933375000
Receivables turnover: 9.15979381443299
Capitalized R&D asset: 19210280
ROCI (R&D-adjusted, %): -7.237103980197844
Rosenberg metric: -0.0010359116022099447
FCF margin (%): -735.9032076533483
Revenue growth (%): 22.130584192439862
Rule of 40 score: -713.7726234609084
Financial ratios for ACRS — quarterly report dated 2025-09-30
Total revenue: 3299000
Gross profit: 850000
Operating income: -17049000
Net income: -14614000
Capital expenditures: 23000
Operating cash flow: -10932000
Depreciation & amortization: 110000
Net tangible assets: 120100000
Owner earnings: -14527000
Return on net tangible assets (%): -12.095753538717736
Buffett classification: The Gruesome
Stock price: 1.9
Shares outstanding: 139663680
Book value: 120100000
P/B ratio: 2.209500349708576
Market cap (USD): 265360992
Debt to equity: 0
Current ratio: 3.9246225274082165
Quick ratio: 3.9246225274082165
COGS to revenue (%): 74.23461655046984
R&D to revenue (%): 394.9075477417399
SG&A to revenue (%): 147.6508032737193
Free cash flow (dilution-adjusted): -12982000
Buyback yield (%): 0
Retained earnings: -947989000
Receivables turnover: 0.70491452991453
Capitalized R&D asset: 24521550
ROCI (R&D-adjusted, %): -9.196717625662979
Rosenberg metric: 0.08061839461961744
FCF margin (%): -393.513185813883
Revenue growth (%): 85.64997186268992
Rule of 40 score: -307.8632139511931
Financial ratios for ACRS — quarterly report dated 2025-12-31
Total revenue: 1295000
Gross profit: -174000
Operating income: -22334000
Net income: -19795000
Capital expenditures: 24000
Operating cash flow: -13131000
Depreciation & amortization: 102000
Net tangible assets: 103082000
Owner earnings: -19717000
Return on net tangible assets (%): -19.127490735530937
Buffett classification: The Gruesome
Stock price: 3.01
Shares outstanding: 139663680
Book value: 103082000
P/B ratio: 4.078187043324732
Market cap (USD): 420387676.79999995
Debt to equity: 0
Current ratio: 3.3624018153255366
Quick ratio: 3.3624018153255366
COGS to revenue (%): 113.43629343629344
R&D to revenue (%): 1280.6177606177605
SG&A to revenue (%): 430.57915057915056
Free cash flow (dilution-adjusted): -16081000
Buyback yield (%): 0
Retained earnings: -967784000
Capitalized R&D asset: 29090930
ROCI (R&D-adjusted, %): -12.079728820435642
Rosenberg metric: -0.07859993859379798
FCF margin (%): -1241.7760617760616
Revenue growth (%): -60.745680509245226
Rule of 40 score: -1302.5217422853068
Financial ratios for ACRS — annual report dated 2025-12-31
Total revenue: 7826000
Gross profit: 542000
Operating income: -74075000
Net income: -64923000
Capital expenditures: 111000
Operating cash flow: -47113000
Depreciation & amortization: 454000
Net tangible assets: 103082000
Owner earnings: -64580000
Return on net tangible assets (%): -62.64915310141441
Buffett classification: The Gruesome
Stock price: 3.01
Shares outstanding: 139663680
Book value: 103082000
P/B ratio: 4.078187043324732
Market cap (USD): 420387676.79999995
Debt to equity: 0
Current ratio: 3.3624018153255366
Quick ratio: 3.3624018153255366
COGS to revenue (%): 93.07436749297214
R&D to revenue (%): 672.6935854842832
SG&A to revenue (%): 280.7564528494761
Free cash flow (dilution-adjusted): -59608000
Buyback yield (%): 0
Retained earnings: -967784000
Capitalized R&D asset: 107614340
ROCI (R&D-adjusted, %): -34.65253395149205
Rosenberg metric: -0.08098612517120228
FCF margin (%): -761.6662407360081
Revenue growth (%): -58.19444444444445
Rule of 40 score: -819.8606851804526
Financial ratios for ACX.DE — annual report dated 2021-12-31
Total revenue: 54051136.36363637
Operating income: 9373863.636363637
Net income: -18528409.09090909
Capital expenditures: 0
Operating cash flow: 11926136.363636363
Depreciation & amortization: 2609090.909090909
Net tangible assets: 16844318.181818184
Owner earnings: -15919318.18181818
Return on net tangible assets (%): -94.50853403494567
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.75
Shares outstanding: 7018000
Book value: 19365909.090909086
P/B ratio: 5.345243516019248
Market cap (USD): 103515500
Debt to equity: 0.09940147869968316
Current ratio: 1.1650129645635263
Quick ratio: 1.1650129645635263
Effective tax rate (%): 6.41182645206438
Interest coverage ratio: 121.30882352941175
COGS to revenue (%): 0
SG&A to revenue (%): 25.651214128035317
Free cash flow (dilution-adjusted): 11926136.363636363
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 45.99899626387109
FCF margin (%): 22.064543256596234
Rule of 40 score: 22.064543256596234
Financial ratios for ACX.DE — annual report dated 2022-12-31
Total revenue: 44720212.76595745
Operating income: 2274468.085106383
Net income: 12667021.276595745
Capital expenditures: 0
Operating cash flow: -5338297.872340426
Depreciation & amortization: 2350000
Net tangible assets: 28302127.65957447
Owner earnings: 15017021.276595745
Return on net tangible assets (%): 53.05969027213953
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.691489361702128
P/E ratio: 3.153296380280507
Shares outstanding: 7018000
Book value: 30796808.510638304
P/B ratio: 1.2969808974403259
Market cap (USD): 39942872.34042553
Debt to equity: 0.06494179418978202
Current ratio: 2.002144062770859
Quick ratio: 2.002144062770859
Interest coverage ratio: 61.08571428571429
COGS to revenue (%): 0
SG&A to revenue (%): 37.99272069843233
Free cash flow (dilution-adjusted): -5338297.872340426
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.247784786824084
FCF margin (%): -11.937103028284605
Revenue growth (%): -17.263140472947427
Rule of 40 score: -29.20024350123203
Financial ratios for ACX.DE — annual report dated 2023-12-31
Total revenue: 40100000
Operating income: -2545555.5555555555
Net income: -1672222.2222222222
Capital expenditures: 0
Operating cash flow: 115555.55555555555
Depreciation & amortization: 1825555.5555555555
Net tangible assets: 28226666.666666664
Owner earnings: 153333.33333333326
Buffett classification: The Gruesome
Stock price: 3.411111111111111
Shares outstanding: 7018000
Book value: 30493333.333333332
P/B ratio: 0.7850626730797259
Market cap (USD): 23939177.777777776
Debt to equity: 0.06307389593353739
Current ratio: 1.6626950496036692
Quick ratio: 1.6626950496036692
Interest coverage ratio: -99.60869565217392
COGS to revenue (%): 0
SG&A to revenue (%): 50.814630091438076
Free cash flow (dilution-adjusted): 115555.55555555555
Buyback yield (%): 0
Retained earnings: 14511111.11111111
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.239106753812636
FCF margin (%): 0.2881684677195899
Revenue growth (%): -10.331374741299342
Rule of 40 score: -10.043206273579752
Financial ratios for ACX.DE — annual report dated 2024-12-31
Total revenue: 43328125
Operating income: -4292708.333333334
Net income: -4637500
Capital expenditures: 0
Operating cash flow: 825000
Depreciation & amortization: 1318750
Net tangible assets: 22247916.666666668
Owner earnings: -3318750
Return on net tangible assets (%): -14.917127071823202
Buffett classification: The Gruesome
Stock price: 2.5833333333333335
Shares outstanding: 7018000
Book value: 23950000
P/B ratio: 0.7569867780097426
Market cap (USD): 18129833.333333336
Debt to equity: 0.06145615866388309
Current ratio: 1.5060021060021058
Quick ratio: 1.5060021060021058
Interest coverage ratio: -42.48453608247423
COGS to revenue (%): 0
SG&A to revenue (%): 47.37107825459791
Free cash flow (dilution-adjusted): 825000
Buyback yield (%): 0
Retained earnings: 8966666.666666668
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.035965274906992
FCF margin (%): 1.9040750090155065
Revenue growth (%): 8.050187032418952
Rule of 40 score: 9.95426204143446
Financial ratios for ACX.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 22247916.666666668
Buffett classification: The Gruesome
Stock price: 2.5833333333333335
Shares outstanding: 7018000
Book value: 23950000
P/B ratio: 0.7569867780097426
Market cap (USD): 18129833.333333336
Debt to equity: 0.06145615866388309
Current ratio: 1.5060021060021058
Quick ratio: 1.5060021060021058
Buyback yield (%): 0
Retained earnings: 8966666.666666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ADANIENSOL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.229724383489387
Shares outstanding: 1201282642
Market cap (USD): 37515725816.32995
Buyback yield (%): 0.00011951557572892704
Retained earnings: 257837267.57220098
Capitalized R&D asset: 0
Rule of 40 score: 0